TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Panadact Life Science AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
1,370
|
1,347 |
| Financial expenses |
1
|
95
|
1 |
| Earnings before taxes |
2,675
|
156
|
515 |
| EBITDA |
-616
|
201
|
317 |
| Total assets |
3,916
|
1,306
|
2,063 |
| Current assets |
442
|
577
|
1,454 |
| Current liabilities |
245
|
419
|
1,050 |
| Equity capital |
3,096
|
422
|
647 |
| - share capital |
50
|
50
|
50 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.1%
|
32.3%
|
31.4% |
| Turnover per employee |
0
|
1,370
|
1,347 |
| Profit as a percentage of turnover |
11.4%
|
38.2% | |
| Return on assets (ROA) |
68.3%
|
19.2%
|
25.0% |
| Current ratio |
180.4%
|
137.7%
|
138.5% |
| Return on equity (ROE) |
86.4%
|
37.0%
|
79.6% |
| Change turnover |
-1,370
|
23
|
321 |
| Change turnover % |
-100%
|
2%
|
31% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.